- Substantial clean room production facility for a leading medical device brand
- Fast-track construction requiring $8 million of work to be put in place each month
- Integration of a new central utility plant in the existing building that is capable of servicing the new campus
Insulet Corporation, the leader in tubeless insulin pump technology (Omnipods), has acquired a property in Acton, MA to serve as its sole U.S.-based manufacturing location. When completed, the facility will provide capacity for Insulet to manufacture up to 70% more Omnipods on a single line with up to 90% fewer personnel than its four locations based in China.
The existing building—a 201,690 sq. ft., three-story office facility—will be converted into high-end campus featuring space for research and development, post-market research and quality control operations; a call center; an employee fitness center with locker rooms; a 7,492 sq. ft. cafeteria and commercial kitchen; and open offices, conference rooms and executive suites. The addition, which will total 110,252 sq. ft., will provide clean room manufacturing and warehouse space; quarantine inspection and receiving areas; a gowning and wash unit; packaging rooms; and a shipping/receiving area. Work will be completed on a fast-track schedule and utilize Lean practices to attain a quick, collaborative start. During construction, our team will pre-fabricate key project elements including the addition’s façade and M/E/P racks to accelerate the schedule and remove labor from the site.